COMPOUNDING AND PHARMACY CAPABILITIES Icon is uniquely positioned to deliver an end-to-end research model backed by the group’s compounding and pharmacy capabilities. Holding long-standing relationships with hospitals, pharmaceutical and manufacturing, Icon provides a collaborative and connected ecosystem conducive to quality management of clinical trials and rigorous research projects.
42
ICON ANNUAL RESEARCH REPORT 2021
